Brief: Deciphera Pharmaceuticals Inc Announces Third Quarter 2022 Financial Results

Deciphera Pharmaceuticals

03/11/2022 11:27

Nov 3 (Reuters) - Deciphera Pharmaceuticals Inc
 DCPH.O :
    * DECIPHERA PHARMACEUTICALS, INC. ANNOUNCES THIRD QUARTER
2022
FINANCIAL RESULTS
    * Q3 2022 TOTAL REVENUE OF $36.0 MILLION
    * QTRLY QINLOCK NET PRODUCT REVENUE INCREASES 49% TO $32.3
MILLION
COMPARED TO Q3 2021
    * QTRLY LOSS PER SHARE $0.55
    * Q3 EARNINGS PER SHARE VIEW $-0.58, REVENUE VIEW $33.2
MILLION --
REFINITIV IBES DATA
    * DECIPHERA PHARMACEUTICALS -  EXPECTS CURRENT CASH, CASH
EQUIVALENTS, & MARKETABLE SECURITIES WILL ENABLE CO TO FUND
OPERATING AND CAPEX INTO 2025

Source text for Eikon:  ID:nBw7H9Qcqa 
Further company coverage:  DCPH.O 
 ((Reuters.Briefs@thomsonreuters.com;))